Crinetics Pharmaceuticals, Inc. (CRNX)
37.09
+0.82
(+2.26%)
USD |
NASDAQ |
May 21, 16:00
37.10
0.00 (0.00%)
After-Hours: 19:59
Crinetics Pharmaceuticals Free Cash Flow : -419.52M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amneal Pharmaceuticals, Inc. | 186.11M |
| Aquestive Therapeutics, Inc. | -44.32M |
| Merck & Co., Inc. | 14.12B |
| Nektar Therapeutics | -203.94M |
| Prestige Consumer Healthcare, Inc. | 246.45M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -124.70M |
| Cash from Investing (Quarterly) | -252.36M |
| Cash from Financing (Quarterly) | 389.88M |
| Free Cash Flow Per Share (Quarterly) | -1.206 |
| Free Cash Flow to Equity (Quarterly) | -124.84M |
| Free Cash Flow to Firm (Quarterly) | -125.52M |
| Free Cash Flow Yield | -11.68% |